Clinical Takeaway Cannabinoid formulations, particularly CBD-containing products, show measurable reductions in anxiety symptoms across multiple study designs, though effect sizes and optimal dosing remain inconsistent across trials. Evidence for Tourette syndrome is...
Endocannabinoid System Research: Cannabis & Teen Mental Health
Clinical Takeaway Adolescents with higher levels of depression and anxiety symptoms were more likely to initiate and use cannabis more frequently over the following 18 months. This longitudinal evidence supports the self-medication...
endocannabinoid system clinical research athletes mental health
Clinical Takeaway Retired professional athletes from high contact team sports such as football, rugby, and ice hockey show elevated rates of depression, anxiety, and cognitive concerns compared to the general population. Key...
Patient Protect launches to tackle discrimination against UK medical cannabis patients
WHY IT MATTERS: If you are a UK medical cannabis patient, dedicated legal support services are now available to help you challenge discrimination in employment, housing, and policing situations that may arise from your prescription. CLINICAL OVERVIEW: Medical cannabis patients in the United Kingdom continue to face real-world consequences that extend well beyond their clinical care, including discrimination in housing decisions, workplace policies, law enforcement encounters, and driving eligibility assessments. These challenges arise because legal frameworks and institutional policies have not kept pace with the formal recognition of medical cannabis as a legitimate prescribed treatment.
Kansas Democrats push cannabis decriminalization, GOP leadership blocks a vote – KWCH
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. Policy Why This Matters Clinicians in Kansas need to understand that cannabis remains fully criminalized...
Senate bill could allow off-duty fire and rescue workers to use medical marijuana – Baltimore Sun
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicySafetyMental Health Why This Matters This legislation directly affects occupational health management for first responders...
Patient Protect launches to tackle discrimination against UK medical cannabis patients
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyMental HealthSafety Why This Matters Clinicians prescribing medical cannabis need to inform patients that legal...
endocannabinoid system clinical research: Mobile Mental Health RCT
Clinical Takeaway A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use concerns during the vulnerable college transition period. Digital tools like...
`Endocannabinoid System & Athlete Mental Health Research`
Clinical Takeaway Retired professional athletes from high contact team sports face elevated rates of depression, anxiety, and cognitive concerns compared to the general population, with factors like repetitive head impacts, abrupt career...
Endocannabinoid System Research: GLP-1 and Mental Health
Clinical Takeaway GLP-1 receptor agonists, the drug class that includes medications like semaglutide, were examined using Mendelian randomization to determine whether they causally affect the risk of ten common mental health conditions,...